RadNet, Inc. Revenue
RadNet, Inc. (RDNT) reported Revenue of $461.14 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Income Statement › Revenue
us-gaap:Revenues · last filed 2024-11-12
- RadNet, Inc. revenues for the quarter ending 2024-09-30 was $461.14M, a 14.72% increase year-over-year.
- RadNet, Inc. revenues for the quarter ending 2024-06-30 was $459.71M, a 13.87% increase year-over-year.
- RadNet, Inc. revenues for the quarter ending 2024-03-31 was $431.71M, a 10.53% increase year-over-year.
- RadNet, Inc. revenues for the quarter ending 2023-12-31 was $420.38M, a 9.51% increase year-over-year.
- RadNet, Inc. revenues for fiscal 2023 was $1.62B, a 13.05% increase from fiscal 2022.
- RadNet, Inc. revenues for fiscal 2022 was $1.43B, a 8.74% increase from fiscal 2021.
- RadNet, Inc. revenues for fiscal 2021 was $1.32B, a 22.69% increase from fiscal 2020.
- RadNet, Inc. revenues for fiscal 2020 was $1.07B, a 7.13% decline from fiscal 2019.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month |
|---|---|---|---|---|---|---|---|
| 2024-09-30 | $461.14M 10-Q · filed 2024-11-12 | $920.86M derived: sum of 2 quarters · filed 2024-11-12 | $1.35B 10-Q · filed 2024-11-12 | $1.77B derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2024-06-30 | $459.71M 10-Q · filed 2024-08-09 | $891.42M 10-Q · filed 2024-08-09 | $1.31B derived: sum of 3 quarters · filed 2024-08-09 | $1.71B derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2024-03-31 | $431.71M 10-Q · filed 2024-05-10 | $852.09M derived: sum of 2 quarters · filed 2024-05-10 | $1.25B derived: sum of 3 quarters · filed 2024-11-12 | $1.66B derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-12-31 | $420.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $822.35M derived: sum of 2 quarters · filed 2024-11-12 | $1.23B derived: sum of 3 quarters · filed 2024-11-12 | $1.62B 10-K · filed 2024-02-29 | |||
| 2023-09-30 | $401.97M 10-Q · filed 2024-11-12 | $805.68M derived: sum of 2 quarters · filed 2024-11-12 | $1.20B 10-Q · filed 2024-11-12 | $1.58B derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $403.71M 10-Q · filed 2024-08-09 | $794.28M 10-Q · filed 2024-08-09 | $1.18B derived: sum of 3 quarters · filed 2024-08-09 | $1.53B derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2023-03-31 | $390.56M 10-Q · filed 2024-05-10 | $774.44M derived: sum of 2 quarters · filed 2024-05-10 | $1.12B derived: sum of 3 quarters · filed 2024-05-10 | $1.48B derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2022-12-31 | $383.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $733.92M derived: sum of 2 quarters · filed 2024-02-29 | $1.09B derived: sum of 3 quarters · filed 2024-02-29 | $1.43B 10-K · filed 2024-02-29 | |||
| 2022-09-30 | $350.04M 10-Q · filed 2023-11-09 | $704.42M derived: sum of 2 quarters · filed 2023-11-09 | $1.05B 10-Q · filed 2023-11-09 | $1.38B derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-06-30 | $354.38M 10-Q · filed 2023-08-09 | $696.14M 10-Q · filed 2023-08-09 | $1.03B derived: sum of 3 quarters · filed 2024-02-29 | $1.36B derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | $341.77M 10-Q · filed 2023-05-10 | $674.92M derived: sum of 2 quarters · filed 2024-02-29 | $1.01B derived: sum of 3 quarters · filed 2024-02-29 | $1.34B derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | $333.15M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $665.84M derived: sum of 2 quarters · filed 2024-02-29 | $999.76M derived: sum of 3 quarters · filed 2024-02-29 | $1.32B 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $332.69M 10-Q · filed 2022-11-09 | $666.61M derived: sum of 2 quarters · filed 2022-11-09 | $981.93M 10-Q · filed 2022-11-09 | $1.29B derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-06-30 | $333.92M 10-Q · filed 2022-08-09 | $649.24M 10-Q · filed 2022-08-09 | $957.17M derived: sum of 3 quarters · filed 2023-03-01 | $1.25B derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-03-31 | $315.32M 10-Q · filed 2022-05-10 | $623.25M derived: sum of 2 quarters · filed 2023-03-01 | $915.03M derived: sum of 3 quarters · filed 2023-03-01 | $1.11B derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2020-12-31 | $307.94M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $599.71M derived: sum of 2 quarters · filed 2023-03-01 | $790.28M derived: sum of 3 quarters · filed 2023-03-01 | $1.07B 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $291.78M 10-Q · filed 2021-11-09 | $482.34M derived: sum of 2 quarters · filed 2021-11-09 | $763.90M 10-Q · filed 2021-11-09 | $1.06B derived: sum of 4 quarters · filed 2021-11-09 | |||
| 2020-06-30 | $190.57M 10-Q · filed 2021-08-09 | $472.13M 10-Q · filed 2021-08-09 | $772.97M derived: sum of 3 quarters · filed 2021-08-09 | $1.07B derived: sum of 4 quarters · filed 2021-08-09 | |||
| 2020-03-31 | $281.56M 10-Q · filed 2021-05-10 | $582.40M derived: sum of 2 quarters · filed 2021-05-10 | $875.10M derived: sum of 3 quarters · filed 2021-05-10 | $1.16B derived: sum of 4 quarters · filed 2021-05-10 | |||
| 2019-12-31 | $300.84M 10-K · filed 2020-03-16 | $593.53M derived: sum of 2 quarters · filed 2020-11-09 | $882.63M derived: sum of 3 quarters · filed 2020-11-09 | $1.15B 10-K · filed 2022-03-01 | |||
| 2019-09-30 | $292.69M 10-Q · filed 2020-11-09 | $581.79M derived: sum of 2 quarters · filed 2020-11-09 | $853.34M 10-Q · filed 2020-11-09 | $1.11B derived: sum of 4 quarters · filed 2020-11-09 | |||
| 2019-06-30 | $289.10M 10-Q · filed 2020-08-10 | $560.65M 10-Q · filed 2020-08-10 | $817.86M derived: sum of 3 quarters · filed 2020-08-10 | $1.06B derived: sum of 4 quarters · filed 2020-08-10 | |||
| 2019-03-31 | $271.55M 10-Q · filed 2020-05-11 | $528.76M derived: sum of 2 quarters · filed 2020-05-11 | $770.91M derived: sum of 3 quarters · filed 2020-05-11 | $1.02B derived: sum of 4 quarters · filed 2020-05-11 | |||
| 2018-12-31 | $257.21M 10-K · filed 2020-03-16 | $499.36M derived: sum of 2 quarters · filed 2020-03-16 | $743.75M derived: sum of 3 quarters · filed 2020-03-16 | $975.15M 10-K · filed 2021-03-16 | |||
| 2018-09-30 | $242.15M 10-K · filed 2020-03-16 | $217.55M 10-Q · filed 2018-11-09 | $486.54M derived: sum of 2 quarters · filed 2020-03-16 | $717.93M 10-Q · filed 2019-11-12 | $641.14M 10-Q · filed 2018-11-09 | $953.49M derived: sum of 4 quarters · filed 2020-03-16 | |
| 2018-06-30 | $244.40M 10-K · filed 2020-03-16 | $219.42M 10-Q · filed 2018-08-09 | $475.79M 10-Q · filed 2019-08-09 | $423.58M 10-Q · filed 2018-08-09 | $711.34M derived: sum of 3 quarters · filed 2020-03-16 | $938.95M derived: sum of 4 quarters · filed 2020-03-16 | |
| 2018-03-31 | $231.39M 10-K · filed 2020-03-16 | $204.17M 10-Q · filed 2018-05-10 | $466.94M derived: sum of 2 quarters · filed 2020-03-16 | $694.55M derived: sum of 3 quarters · filed 2020-03-16 | $924.57M derived: sum of 4 quarters · filed 2020-03-16 | ||
| 2017-12-31 | $235.55M 10-K · filed 2019-03-18 | $463.16M derived: sum of 2 quarters · filed 2019-03-18 | $693.17M derived: sum of 3 quarters · filed 2019-03-18 | $922.19M 10-K · filed 2020-03-16 | |||
| 2017-09-30 | $227.61M 10-K · filed 2019-03-18 | $211.31M 10-Q · filed 2018-11-09 | $457.62M derived: sum of 2 quarters · filed 2019-03-18 | $638.12M 10-Q · filed 2018-11-09 | |||
| 2017-06-30 | $230.01M 10-K · filed 2019-03-18 | $214.06M 10-Q · filed 2018-08-09 | $426.81M 10-Q · filed 2018-08-09 | ||||
| 2017-03-31 | $229.01M 10-K · filed 2019-03-18 | $212.75M 10-Q · filed 2018-05-10 | |||||
| 2016-12-31 | $884.53M 10-K · filed 2019-03-18 | ||||||
| 2014-09-30 | $98.00M 10-Q · filed 2014-11-10 | $279.60M 10-Q · filed 2014-11-10 | |||||
| 2013-09-30 | $98.30M 10-Q · filed 2014-11-10 | $175.19M 10-Q · filed 2013-11-13 | $121.23M derived: sum of 2 quarters · filed 2014-11-10 | $256.60M 10-Q · filed 2014-11-10 | $524.65M 10-Q · filed 2013-11-13 | -$259.27M derived: sum of 4 quarters · filed 2014-11-10 | |
| 2013-06-30 | $22.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $45.21M 10-Q · filed 2013-08-09 | -$357.57M derived: sum of 3 quarters · filed 2013-08-09 | -$197.12M derived: sum of 4 quarters · filed 2013-11-13 | |||
| 2013-03-31 | $22.28M 10-Q · filed 2013-05-10 | -$380.50M derived: sum of 2 quarters · filed 2013-05-10 | -$220.05M derived: sum of 3 quarters · filed 2013-11-13 | -$199.17M derived: sum of 4 quarters · filed 2013-11-13 | |||
| 2012-12-31 | -$402.78M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$242.33M derived: sum of 2 quarters · filed 2013-11-13 | -$221.45M derived: sum of 3 quarters · filed 2013-11-13 | $85.04M 10-K · filed 2013-03-18 | |||
| 2012-09-30 | $160.45M 10-Q · filed 2013-11-13 | $181.33M derived: sum of 2 quarters · filed 2013-11-13 | $487.82M 10-Q · filed 2013-11-13 | $60.95M 10-Q · filed 2012-11-09 | $222.50M derived: sum of 4 quarters · filed 2013-11-13 | ||
| 2012-06-30 | $20.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $41.95M 10-Q · filed 2013-08-09 | $62.05M derived: sum of 3 quarters · filed 2013-08-09 | ||||
| 2012-03-31 | $21.08M 10-Q · filed 2013-05-10 | $41.17M derived: sum of 2 quarters · filed 2013-05-10 | |||||
| 2011-12-31 | $20.09M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $76.08M 10-K · filed 2013-03-18 | |||||
| 2011-09-30 | $55.98M 10-Q · filed 2012-11-09 | ||||||
| 2010-12-31 | $76.94M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |